ARESTIN

LOE Approaching

minocycline hydrochloride

NDADENTALPOWDER, EXTENDED RELEASE
Approved
Feb 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

Mechanism of Action The mechanism of action of ARESTIN as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis is unknown.

Clinical Trials (1)

NCT02297412Phase 2Completed

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Started Nov 2014
47 enrolled
Acute PainBreast CarcinomaPeripheral Neuropathy
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers